Highbridge Capital Management’s Aspire Biopharma Warrant ASBPW Stock Holding History

Highbridge Capital Management’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Hold	0	–	–	–	358
2025 Q4	–	Hold	0	–	–	–	278
2025 Q3	–	Hold	0	–	–	–	268
2025 Q2	–	Hold	0	–	–	–	233
2025 Q1	–	Hold	0	–	–	–	152
2024 Q4	–	Hold	0	–	–	–	216
2024 Q3	–	Hold	0	–	–	–	216
2024 Q2	–	Hold	0	–	–	–	239
2024 Q1	–	Hold	0	–	–	–	271
2023 Q4	–	Hold	0	–	–	–	221
2023 Q3	–	Hold	0	–	–	–	333
2023 Q2	–	Hold	0	–	–	–	409
2023 Q1	–	Hold	0	–	–	–	444
2022 Q4	–	Hold	0	–	–	–	490
2022 Q3	–	Hold	0	–	–	–	451
2022 Q2	–	Hold	0	–	–	–	478

Other funds holding ASBPW

Mint Tower Capital Management Amsterdam, Netherlands $1.08B AUM 19.06% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return